Virginia Man-Yee Lee

Philadelphia, PA, United States of America

Virginia Man-Yee Lee

This inventor holds 24 USPTO granted patents and 12 published patent applications, primarily in Neurodegenerative Treatments. Top assignees: University of Pennsylvania, University of California. Active years: 1992-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Virginia Man-Yee Lee. Retrieved from https://idiyas.com/inventor/virginia-man-yee-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 

% Patents Active = 100.0

Average Co-Inventor Count = 3.1

ph-index = 6

Forward Citations = 397(Granted Patents)


Company Filing History:


Years Active: 1992-2024

Loading Chart...
Areas of Expertise:
Monoclonal Antibodies
Alpha-Synuclein
Neurodegenerative Diseases
Tauopathies
Microtubule Stabilization
Amyloid Plaque Inhibitors
GSK-3 Regulation
Neuronal Cell Transplants
Diagnostic Imaging
Thromboxane A2 Antagonists
Human Neurons
Phosphorylated Tau
24 patents (USPTO):Explore Patents

Title: Virginia M Y Lee: Pioneering Innovations in Neurodegenerative Disease Treatment

Introduction

Virginia M Y Lee is a distinguished inventor based in Philadelphia, PA, United States. With a remarkable portfolio that includes 11 patents, she has made significant contributions to the field of biomedical science, particularly in the study and treatment of neurodegenerative diseases.

Latest Patents

Among her latest innovations are groundbreaking patents that focus on monoclonal antibodies against alpha-synuclein fibrils. This invention provides antibodies that specifically bind to α-Synuclein, demonstrating a preference for the fibrillar form over the monomeric form. This discovery not only aids in the treatment of α-Synucleopathic diseases but also establishes methods for detecting these fibrils effectively.

Another notable patent involves substituted [1,2,4]triazolo[1,5-a]pyrimidines, which serve as stabilizers for microtubules. This innovation includes compounds that provide a method for stabilizing microtubules in patients, offering therapeutic avenues for both cancer and neurodegenerative diseases.

Career Highlights

Virginia has pursued her research at prominent institutions, including the University of Pennsylvania and the University of California. Her dedication and expertise have positioned her as a key figure in her field, driving forward the understanding and treatment of neurodegenerative disorders.

Collaborations

Throughout her career, Virginia has collaborated with esteemed colleagues, including John Q Trojanowski and Kurt R Brunden. These collaborations have been pivotal in advancing research and fostering innovative solutions in her areas of expertise.

Conclusion

Virginia M Y Lee stands out as a trailblazer in medical research and innovation. Her contributions through her patents not only underline her significant role as an inventor but also highlight the potential for future advancements in treating complex diseases. With a focus on neurodegenerative conditions, her work continues to inspire and propel research in the biomedical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…